BioXcel Therapeutics Provides an Update on its Ongoing Phase 3 SERENITY Trials
More than one-third of the SERENITY I & II patients have been dosed, including over 100 bipolar patientsOn track to […]
More than one-third of the SERENITY I & II patients have been dosed, including over 100 bipolar patientsOn track to […]
DENVER, March 19, 2020 (GLOBE NEWSWIRE) — HighPoint Resources Corporation (“we”, “us”, or the “Company”) (NYSE: HPR) announced today an […]
NEWMARKET, Ontario, March 19, 2020 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX:BOS), today announced an update on its business […]
TORONTO, March 19, 2020 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX)(OTCQB: ENGMF)(FSE: 2AV) […]
MOUNTAIN VIEW, Calif., March 19, 2020 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on […]
The OVAL Phase 3 potential-registration study of VB-111 in ovarian cancer continues as planned towards the important interim analysis in […]
SHAGHAI, China, March 19, 2020 (GLOBE NEWSWIRE) — Molecular Data Inc. (“Molecular Data” or the “Company”) (NASDAQ: MKD), a leading […]
BOISE, Idaho, March 19, 2020 (GLOBE NEWSWIRE) — US Ecology, Inc. (“US Ecology” or “the Company”), in response to the […]
CANTON, Mass., March 19, 2020 (GLOBE NEWSWIRE) — Destination XL Group, Inc. (NASDAQ: DXLG), the largest omni-channel specialty retailer of […]
WALTHAM, Mass., March 19, 2020 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (“we,” “us,” “our” or “GECC”), (NASDAQ: GECC), today […]